Annual Drug Patent Expirations for ACTOPLUS+MET+XR Actoplus Met Xr is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are five patents protecting this drug…
The post New patent expiration for Takeda Pharms drug ACTOPLUS MET XR ap…
New patent expiration for Takeda Pharms drug ACTOPLUS MET XR Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Finland? Read Post »
The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value of their drug patents before the exclusivity period expires. In…
The post Maximizing Drug Patents’ Value: S…
Maximizing Drug Patents’ Value: Strategies for Biomedical Companies Read Post »
This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…
The post Which pharma companies have the m…
Which pharma companies have the most supplementary protection certificates? Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Annual Drug Patent Expirations for QDOLO Qdolo is a drug marketed by Athena and is included in one NDA. It is available from three suppliers. There is one patent protecting…
The post New patent for Athena drug QDOLO appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for REZLIDHIA Rezlidhia is a drug marketed by Rigel Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Rigel Pharms drug REZLIDHIA appeared first on DrugPatent…
Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are six patents protecting…
The post New patent for Chiesi drug FERRIPROX appeared first on Dru…
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and…
The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are thirteen patents…
The post New patent for Axsome Malta drug SUNOSI appeared first on DrugPaten…
Get new actionable insights and updates from BiotechBlog
